36.25
price up icon3.10%   1.09
after-market アフターアワーズ: 36.25
loading
前日終値:
$35.16
開ける:
$35.25
24時間の取引高:
24,007
Relative Volume:
1.03
時価総額:
$211.01M
収益:
-
当期純損益:
$-7.12M
株価収益率:
-15.76
EPS:
-2.3
ネットキャッシュフロー:
$-6.82M
1週間 パフォーマンス:
+3.54%
1か月 パフォーマンス:
+12.89%
6か月 パフォーマンス:
+57.75%
1年 パフォーマンス:
+5,054%
1日の値動き範囲:
Value
$34.91
$36.25
1週間の範囲:
Value
$31.84
$36.25
52週間の値動き範囲:
Value
$0.3438
$54.30

Monopar Therapeutics Inc Stock (MNPR) Company Profile

Name
名前
Monopar Therapeutics Inc
Name
セクター
Healthcare (1160)
Name
電話
(847) 388-0349
Name
住所
1000 SKOKIE BLVD SUITE 350, WILMETTE
Name
職員
16
Name
Twitter
Name
次回の収益日
2024-11-07
Name
最新のSEC提出書
Name
MNPR's Discussions on Twitter

MNPR を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Biotechnology icon
MNPR
Monopar Therapeutics Inc
36.25 211.01M 0 -7.12M -6.82M -2.30
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
459.62 115.95B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
547.36 56.52B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
331.91 39.44B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
543.48 35.14B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
245.49 28.51B 3.81B -644.79M -669.77M -6.24

Monopar Therapeutics Inc Stock (MNPR) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2025-03-19 再開されました Piper Sandler Overweight
2025-01-10 開始されました Piper Sandler Overweight
2024-10-11 開始されました Rodman & Renshaw Buy
2021-01-28 開始されました ROTH Capital Buy

Monopar Therapeutics Inc (MNPR) 最新ニュース

pulisher
Jun 13, 2025

Wall Street Analysts Predict a 51.26% Upside in Monopar Therapeutics (MNPR): Here's What You Should Know - MSN

Jun 13, 2025
pulisher
Jun 12, 2025

Monopar Therapeutics (NASDAQ:MNPR) Trading 0.4% Higher – Time to Buy? - Defense World

Jun 12, 2025
pulisher
Jun 11, 2025

Monopar Therapeutics Inc. and Excel Diagnostics and Nuclear Oncology Center Announce Expanded Access Program for Mnpr-101-Zr and Mnpr-101-Lu in Advanced Cancers - MarketScreener

Jun 11, 2025
pulisher
Jun 11, 2025

Monopar and EDNOC Announce Expanded Access Program for MNPR-101- - GuruFocus

Jun 11, 2025
pulisher
Jun 11, 2025

Monopar Therapeutics (MNPR) Gains FDA Nod for Expanded Access Program | MNPR Stock News - GuruFocus

Jun 11, 2025
pulisher
Jun 11, 2025

Monopar Therapeutics Announces FDA Authorization for Expanded Access Program of Investigational Agents MNPR-101-Zr and MNPR-101-Lu in Collaboration with Excel Diagnostics - Nasdaq

Jun 11, 2025
pulisher
Jun 11, 2025

FDA Greenlights Expanded Access: New Treatment Hope for Breast, Pancreatic, and Colorectal Cancer Patients - Stock Titan

Jun 11, 2025
pulisher
Jun 10, 2025

Learn to Evaluate (MNPR) using the Charts - news.stocktradersdaily.com

Jun 10, 2025
pulisher
Jun 09, 2025

Head to Head Contrast: Monopar Therapeutics (NASDAQ:MNPR) vs. Climb Bio (NASDAQ:CLYM) - Defense World

Jun 09, 2025
pulisher
Jun 05, 2025

Monopar Therapeutics (MNPR) Gains Buy Rating and $71 Price Targe - GuruFocus

Jun 05, 2025
pulisher
Jun 05, 2025

Monopar Therapeutics (MNPR) Gains Buy Rating and $71 Price Target | MNPR Stock News - GuruFocus

Jun 05, 2025
pulisher
Jun 03, 2025

Monopar Therapeutics (MNPR) Set for Inclusion in Russell Indexes - GuruFocus

Jun 03, 2025
pulisher
Jun 03, 2025

Monopar Therapeutics (MNPR) Set for Inclusion in Russell Indexes | MNPR Stock News - GuruFocus

Jun 03, 2025
pulisher
Jun 03, 2025

Monopar Therapeutics Announces Inclusion in the Russell 3000® and Russell 2000® Indexes - The Manila Times

Jun 03, 2025
pulisher
Jun 03, 2025

Monopar joins Russell 3000 and 2000 indexes, growth acknowledged By Investing.com - Investing.com UK

Jun 03, 2025
pulisher
Jun 03, 2025

Monopar Therapeutics Added to Russell Indexes, Gains Access to $10.6T Benchmark Assets - Stock Titan

Jun 03, 2025
pulisher
May 20, 2025

Piper Sandler Reaffirms Their Buy Rating on Monopar Therapeutics Inc (MNPR) - The Globe and Mail

May 20, 2025
pulisher
May 18, 2025

(MNPR) Trading Advice - news.stocktradersdaily.com

May 18, 2025
pulisher
May 17, 2025

Research Analysts Offer Predictions for MNPR Q2 Earnings - Defense World

May 17, 2025
pulisher
May 14, 2025

Monopar Therapeutics Inc. Announces Closing of $19.2 Million Public Offering of Common Stock - The Globe and Mail

May 14, 2025
pulisher
May 14, 2025

Monopar Therapeutics Inc reports results for the quarter ended March 31Earnings Summary - TradingView

May 14, 2025
pulisher
May 13, 2025

Monopar (MNPR) Projects Financial Stability Through 2026 | MNPR Stock News - GuruFocus

May 13, 2025
pulisher
May 13, 2025

Monopar Therapeutics reports Q1 EPS (38c), consensus (57c) - TipRanks

May 13, 2025
pulisher
May 13, 2025

Monopar Therapeutics Reports First Quarter 2025 Financial Results and Recent Developments - The Manila Times

May 13, 2025
pulisher
May 13, 2025

Monopar Therapeutics SEC 10-Q Report - TradingView

May 13, 2025
pulisher
May 08, 2025

2,037 Shares in Monopar Therapeutics Inc. (NASDAQ:MNPR) Acquired by JPMorgan Chase & Co. - Defense World

May 08, 2025
pulisher
May 07, 2025

(MNPR) Proactive Strategies - news.stocktradersdaily.com

May 07, 2025
pulisher
May 07, 2025

Monopar Therapeutics (MNPR) Showcases ALXN1840's Efficacy for Wi - GuruFocus

May 07, 2025
pulisher
May 07, 2025

Monopar Therapeutics Inc expected to post a loss of 68 cents a shareEarnings Preview - TradingView

May 07, 2025
pulisher
May 07, 2025

Monopar Therapeutics Highlights ALXN1840 Data at EASL 2025 - TipRanks

May 07, 2025
pulisher
May 07, 2025

Monopar Therapeutics (MNPR) Showcases ALXN1840's Efficacy for Wilson Disease | MNPR Stock News - GuruFocus

May 07, 2025
pulisher
May 07, 2025

Monopar Therapeutics (MNPR) Expected to Announce Quarterly Earnings on Thursday - Defense World

May 07, 2025
pulisher
May 07, 2025

Monopar Presents ALXN1840 Late-Breaker Data at EASL 2025 | MNPR Stock News - GuruFocus

May 07, 2025
pulisher
May 07, 2025

Monopar Presents ALXN1840 Late-Breaker Data at EASL 2025 - The Manila Times

May 07, 2025
pulisher
May 02, 2025

Geode Capital Management LLC Acquires 24,530 Shares of Monopar Therapeutics Inc. (NASDAQ:MNPR) - Defense World

May 02, 2025
pulisher
Apr 30, 2025

Why Monopar Therapeutics Inc. (MNPR) is Surging in 2025 - Insider Monkey

Apr 30, 2025
pulisher
Apr 29, 2025

Monopar Announces ALXN1840 Data Selected for Late-Breaker Presentation at EASL Congress 2025 - The Manila Times

Apr 29, 2025
pulisher
Apr 29, 2025

Why These 15 Healthcare Stocks Are Surging in 2025 - Insider Monkey

Apr 29, 2025
pulisher
Apr 25, 2025

U.S. Severe Oral Mucositis Market Projected To Witness - openPR.com

Apr 25, 2025
pulisher
Apr 22, 2025

(MNPR) Investment Analysis - news.stocktradersdaily.com

Apr 22, 2025
pulisher
Apr 10, 2025

Monopar Therapeutics Inc. acquired worldwide license to ALXN-18 from Alexion Pharmaceuticals, Inc. for approximately $110 million. - marketscreener.com

Apr 10, 2025
pulisher
Apr 06, 2025

(MNPR) Long Term Investment Analysis - news.stocktradersdaily.com

Apr 06, 2025
pulisher
Apr 04, 2025

Major Shareholder Sells Big Chunk of Monopar Therapeutics Stock! - TipRanks

Apr 04, 2025
pulisher
Apr 04, 2025

Monopar Therapeutics CEO Robinson sells $1.17 million in stock By Investing.com - Investing.com Canada

Apr 04, 2025
pulisher
Apr 04, 2025

Jones Trading Reiterates “Hold” Rating for Monopar Therapeutics (NASDAQ:MNPR) - Defense World

Apr 04, 2025
pulisher
Apr 04, 2025

HC Wainwright Issues Negative Forecast for MNPR Earnings - Defense World

Apr 04, 2025
pulisher
Apr 03, 2025

What is HC Wainwright’s Forecast for MNPR FY2029 Earnings? - Defense World

Apr 03, 2025
pulisher
Apr 02, 2025

Monopar Therapeutics downgraded to Hold from Buy at JonesResearch - TipRanks

Apr 02, 2025
pulisher
Apr 02, 2025

We Think Monopar Therapeutics (NASDAQ:MNPR) Can Easily Afford To Drive Business Growth - Yahoo

Apr 02, 2025

Monopar Therapeutics Inc (MNPR) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$20.30
price down icon 0.68%
$36.37
price up icon 0.50%
$24.55
price up icon 8.53%
$97.80
price down icon 0.45%
$110.00
price up icon 1.61%
biotechnology ONC
$245.49
price up icon 0.48%
大文字化:     |  ボリューム (24 時間):